ROS‐Responsive Eye Drop for Controlled Release of 20‐Deoxyingenol Improves Diabetic Corneal Healing by Activating Macrophage Autophagy and Metabolic Reprogramming
ABSTRACT Impaired corneal wound healing in diabetes remains a major clinical challenge, driven by defective autophagy, metabolic dysregulation, and sustained inflammation within a high‐reactive oxygen species (ROS) microenvironment. Here, we engineered a ROS‐responsive ocular delivery system based on N1‐(4‐boronobenzyl...